dr. goldberg on pd-l1 as a biomarker in lung cancer
Published 7 years ago • 218 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
1:42
dr. gandara discusses pd-l1 as a biomarker in lung cancer
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
2:13
the value of pd-l1 as a biomarker beyond lung cancers
-
5:02
dr blythe adamson: pd-l1 as a predictive biomarker in lung cancer continues to evolve
-
1:34
evolving role of pd-l1 as a biomarker
-
1:14
dr. gupta on pd-l1 as a biomarker in kidney cancer
-
5:06
should pd-l1 be used as a biomarker for immunotherapy in lung cancer?
-
2:24
dr. weiss on pd-l1 biomarker in lung cancer
-
1:03
dr. barbara j. gitlitz on why pd-l1 is not a good biomarker for immunotherapy in lung cancer
-
1:50
dr. goldberg on immune/targeted therapy combos in oncogene-driven lung cancer
-
3:50
the role of pd-l1: is it accurate enough as a biomarker for immunotherapy response?
-
10:20
pd-l1 testing in advanced lung cancer
-
4:50
nsclc: challenges with pd-l1 as biomarker
-
9:54
is the pd-l1 biomarker ready for prime time?
-
1:12
dr. sharma on pd-l1 as biomarker for immunotherapy in bladder cancer
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
0:51
dr. rizvi on pd-l1 as a biomarker for immunotherapy agents in lung cancer